Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-2-24
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0263-7103
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
84-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8422571-Adult,
pubmed-meshheading:8422571-Arthritis,
pubmed-meshheading:8422571-Gemfibrozil,
pubmed-meshheading:8422571-Humans,
pubmed-meshheading:8422571-Hyperlipoproteinemia Type II,
pubmed-meshheading:8422571-Male,
pubmed-meshheading:8422571-Raynaud Disease,
pubmed-meshheading:8422571-Vasculitis
|
pubmed:year |
1993
|
pubmed:articleTitle |
Vasculitis, Raynaud's phenomenon and polyarthritis associated with gemfibrozil therapy.
|
pubmed:publicationType |
Letter,
Case Reports
|